CEPHEID UK LIMITED

1. CEPHEID UK LIMITED 2009-01-28 → present
2. STRETTON SCIENTIFIC LIMITED 2002-04-22 → 2009-01-28

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 101

Reporting scope

Standalone (parent only)

Auditor

Ernst & Young LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The directors have performed a going concern assessment for the period to 31 December 2026 (the assessment period), taking into account the potential impact of uncertainties on the business, including the impact of mitigation measures, within their forecasts. As a limited risk distributor, the Company is trading profitably with a positive cash flow and a very strong balance sheet throughout the assessment period. Whilst not forecasted to be required, the group cash pool arrangement is also available if the Company requires immediate access to cash funds in order to meet liabilities as they fall due. The cash position of the UK Group cash pools is strong and therefore the Company has access to sufficient operating funds as necessary. After making due enquiries, considering the forecasts and potential downside scenarios due to the risks highlighted above, cross guarantees with fellow group members of the cash pool and strength of the ultimate parent company, Danaher Corporation, the directors have a reasonable expectation that the Company has adequate resources to continue in operation for the going concern assessment period. Accordingly, they have prepared these financial statements on a going concern basis.”

Group structure

1. CEPHEID UK LIMITED · parent
   1. Cepheid Diagnostics & Lifesciences (Private) Limited 100% · Zimbabwe · Diagnostics
   2. Cepheid Diagnostics And Life Sciences Limited 100% · Kenya · Diagnostics
   3. Cepheid Switzerland LLC 100% · Switzerland · Diagnostics

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

6

last 12 months

Capital events

0

last 24 months

Officers appointed

1

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  +4.8%

  £63,786,915 → £66,832,945

• Cash

  -39.7%

  £20,499,376 → £12,351,241

• Net assets

  -29.5%

  £9,860,862 → £6,952,639

• Employees

  -6.3%

  63 → 59

• Operating profit

  -14.7%

  £4,037,595 → £3,444,586

• Profit before tax

  -22.8%

  £5,277,548 → £4,073,588

• Wages

  +7.5%

  £6,192,710 → £6,658,716

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers